Nasrazadani A, Tidwell RS, Kai M, Lim B, et al. Retrospective review of metastatic hormone receptor-positive inflammatory breast
cancer patients reveals poor responses to cyclin dependent kinase 4/6 inhibition. Breast Cancer Res 2025 Dec 10. doi: 10.1186/s13058-025-02162.
PMID: 41372771
|